AIDS Vaccine Advocacy Coalition Inc logo

Integrated Preclinical/Clinical Program for HIV Topical Microbicides and Biomedical Prevention (RFA-AI-14-025)

AIDS Vaccine Advocacy Coalition Inc

Funding Amount

Varies

Deadline

Rolling / Open

Grant Type

Foundation

Can we apply?

Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.

Other requirements

  • Single institutions
  • Consortia of institutions
  • Note: This FOA contains significant modifications to previous iterations of the Integrated Preclinical Clinical Program FOA.

Overview

Goal: An integrated, iterative multidisciplinary application for developing a microbicide, Pre-Exposure Prophylaxis (PrEP), or Multipurpose Prevention Technology (MPT) non-vaccine biomedical prevention (nBP) product or strategy.

Purpose: To solicit applications from single institutions and consortia of institutions to participate in the Integrated Preclinical Clinical Program for HIV Topical Microbicides and Biomedical Prevention (IPCP-MBP). The objective is to create an integrated and iterative multi-disciplinary application with the goal of developing biomedical HIV prevention products or strategies.

Focus Areas:

  • Microbicides for HIV prevention
  • Pre-Exposure Prophylaxis (PrEP)
  • Multipurpose Prevention Technologies (MPT)
  • Non-vaccine biomedical prevention strategies
  • Products for use in male and/or female genital and gastrointestinal (GI) tracts
  • Prevention of HIV acquisition and transmission

Product Delivery Systems:

  • Gels
  • Films
  • Quick dissolving tablets
  • Intravaginal rings (IVR)
  • Implants
  • Oral formulations
  • Injections

Eligibility:

  • Single institutions
  • Consortia of institutions

Note: This FOA contains significant modifications to previous iterations of the Integrated Preclinical Clinical Program FOA.

What AIDS Vaccine Advocacy Coalition Inc actually gave

Source: IRS Form 990, 2024

Grants in 2024
4
Total given
$1.04M
Median grant
$193K
Range
$98K–$555K
  • By dollars: Massachusetts 53%, New York 22%, North Carolina 15%. Top recipient cities: Boston, MA; New York, NY; Durham, NC.

Example grants

  • Clinton Health Access Initiative · Boston, MA

    To create a platform

    $555K

  • International AIDS Vaccine Initiative · New York, NY

    Hiv vaccine and biom

    $227K

  • Family Health International 360 · Durham, NC

    Hiv vaccine and biom

    $160K

  • Internews · Arcata, CA

    Hiv vaccine and biom

    $98K

IRS Form 990, 2024. Amounts as reported by the funder. Full 990 history →

Focus Areas & Funding Uses

Fields of Work

  • HIV/AIDS
  • Science research

Categories

Browse similar grants by category

Related Grants

Open grants from this funder and similar programs

Your AI grants department

Ready to apply for Integrated Preclinical/Clinical Program for HIV Topical Microbicides and Biomedical Prevention (RFA-AI-14-025)?

Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.

You found Integrated Preclinical/Clinical Program for HIV Topical Microbicides and Biomedical Prevention (RFA-AI-14-025). Now let's win it.

Start writing